China's Anemia Supplement Market Surges +81.4% on Snackable Innovation
By Jotham Lim
6 min read
Executive Summary
Anemia Improvement is the fastest-growing functional supplement category in China's online health and wellness market, surging +81.4% year-on-year (YoY) to reach CN¥ 3.18 billion in 2025 sales with 27.04 million units sold (+114.4% YoY). The explosive growth is fueled by snackable formats -- iron-fortified gummies and flavored oral solutions -- that reframe blood health as an approachable daily wellness habit for young working women, rather than a clinical intervention.
Download Full Report
Get the complete analysis with additional data, methodology details, and brand-level insights.
Market Growth: A Category Transformed
The anemia supplements segment posted the strongest growth of any functional category tracked by Moojing Market Intelligence (魔镜洞察) in 2025. Sales reached CN¥ 3.18 billion (+81.4% YoY), while unit volume more than doubled to 27.04 million units (+114.4% YoY) [1]. The volume growth outpacing revenue signals that brands are competing aggressively on accessibility and trial, pulling first-time buyers into the category through lower Average Selling Price (ASP) entry points.
Policy tailwinds are reinforcing commercial momentum. China's National Nutrition Plan explicitly targets reducing anemia prevalence by 2030, creating sustained awareness and legitimacy for supplement-based interventions [2]. As government health campaigns normalize preventive supplementation, brands benefit from a consumer base primed to view iron and blood-nourishing products as routine rather than remedial.
Sales exhibit a clear seasonal pattern, building steadily from January through a Q3 peak, with October recording the highest monthly sales at CN¥ 342.6 million. The late-summer surge aligns with back-to-school health preparation and pre-winter wellness stocking, while November and December taper as promotional intensity shifts to general e-commerce festivals.
Anemia Improvement sales build throughout 2025, peaking at CN¥ 343M in October
Brand Landscape: Triple-Digit Growth Across the Board
The competitive landscape reveals a rare phenomenon: every single top 10 brand achieved triple-digit or higher YoY growth. This uniformity signals that the category itself is in a steep adoption curve, lifting all boats rather than redistributing share among incumbents [3].
Fiboo leads with 11.6% market share (CN¥ 370 million), driven by its sugar-free iron-fortified gummy that combines functional efficacy with confectionery appeal. Minayo holds second position at 7.9% market share through its Advanced Iron Element Gummy. The gummy format dominates the top ranks, confirming that form factor innovation -- not just ingredient science -- is the primary growth driver.
The standout growth story belongs to Five Female PhDs (五个女博士), which posted an extraordinary +45,566.7% YoY surge. While this figure reflects a near-zero base, it illustrates how rapidly new entrants can scale in a category where consumer demand is outstripping supply. Smeal's Enhanced Women's Biotin Keratin Black Pill also demonstrates cross-functional positioning, merging anemia support with beauty-from-within claims at a premium ASP of CN¥ 255.5.
Top 10 Anemia Improvement Brands
| Brand | Sales (CN¥ 100M) | Volume (M units) | Avg. Price (CN¥) | Market Share | YoY Growth (%) | Best-Selling Product |
|---|---|---|---|---|---|---|
| Fiboo | 3.7 | 306.4 | 120.2 | 11.6% | +487.2% | Sugar-Free Iron-Fortified Gummy |
| Minayo | 2.5 | 211.6 | 119.3 | 7.9% | +165.0% | Minayo Advanced Iron Element Gummy |
| Smeal | 2.2 | 90.5 | 255.5 | 6.8% | +4,632.9% | Enhanced Women's Biotin Keratin Black Pill |
| Five Female PhDs | 2.1 | 136.8 | 154.4 | 6.6% | +45,566.7% | Iron-Fortified Gummy |
| Yizhibao | 1.9 | 64.6 | 285.4 | 5.8% | +347.1% | Red Queen Blood-Nourishing Iron Supplement Powder |
| Hong Tao K | 1.5 | 58.7 | 258.4 | 4.8% | +130.5% | Hematopoietic Blood-Nourishing Oral Solution |
| Salus | 1.1 | 64.5 | 165.6 | 3.4% | +410.6% | Iron Supplement Oral Solution |
| Huebner | 1.0 | 41.0 | 233.8 | 3.0% | +317.5% | Qi & Blood-Nourishing Oral Solution |
| Floradix | 0.9 | 46.4 | 199.6 | 2.9% | +317.5% | Floradix Iron + Qi-Blood Supplement |
| Swisse | 0.8 | 56.6 | 139.8 | 2.5% | +595.5% | Swisse Blood-Nourishing Iron Supplement Tablets |
The brand landscape splits into two distinct pricing tiers:
- Accessible gummy brands (ASP CN¥ 119-155): Fiboo, Minayo, Five Female PhDs, Swisse -- high volume, mass market penetration
- Premium solution/powder brands (ASP CN¥ 234-285): Yizhibao, Hong Tao K, Smeal, Huebner -- lower volume, higher margin, efficacy-led positioning
- Mid-tier oral solutions (ASP CN¥ 166-200): Salus, Floradix -- European heritage brands anchoring clinical credibility
Ingredient Trends: Folic Acid Leads, Novel Iron Surges
The ingredient landscape reflects a market in transition between established nutritional staples and emerging bioavailable iron innovations. Folic acid commands the largest ingredient segment at CN¥ 153.3 million (+92.9% YoY), followed by vitamin C at CN¥ 137.1 million (+52.8% YoY) [4]. These two ingredients frequently appear together in synergistic formulations, as vitamin C enhances non-heme iron absorption -- a science-backed pairing that resonates with educated consumers.
The most notable growth stories emerge from novel iron sources. Ferrous fumarate surged +250.5% YoY, and ferric pyrophosphate grew +118.3%, signaling manufacturer investment in gentler, higher-bioavailability iron compounds that reduce the gastrointestinal side effects associated with traditional ferrous sulfate. Nano iron, while still a niche ingredient at CN¥ 0.7 million, posted +357.9% YoY growth, pointing toward next-generation delivery technologies.
Conversely, vitamin B12 declined -49.6% YoY and ferrous glycinate fell -72.5%, suggesting consumer and formulator migration away from older-generation ingredients toward more differentiated compounds.
Folic acid leads anemia ingredients at CN¥ 153M while ferrous fumarate surges +251%
Consumer Purchase Drivers: Scenario Trumps Science
Perhaps the most strategically significant finding is that usage scenario drives 29.9% of purchase decisions -- nearly double the weight of any other factor [5]. Consumers are not selecting anemia products based primarily on ingredients or clinical claims; they are choosing products that fit specific life situations.
Usage scenario drives 29.9% of anemia product purchase decisions
Key Takeaways
- Anemia Improvement surged +81.4% YoY to CN¥ 3.18 billion, making it the fastest-growing functional supplement category in China's online market
- Every top 10 brand achieved triple-digit or higher YoY growth, led by Fiboo at 11.6% market share with sugar-free iron gummies
- Folic acid (CN¥ 153.3 million) and vitamin C (CN¥ 137.1 million) lead the ingredient landscape, while novel iron sources like ferrous fumarate surged +250.5%
- Usage scenario drives 29.9% of purchase decisions -- young working women frame iron supplements as energy-management tools for demanding lifestyles
- Snackable formats, sugar-free claims, and beauty-from-within positioning are redefining anemia supplements from clinical remediation to daily wellness ritual
More from This Report
## About the Data
This analysis draws on Moojing Market Intelligence data covering January-December 2025. Moojing tracks 400,000+ brands across 30+ e-commerce platforms, representing 58-65% of China's online retail Gross Merchandise Value (GMV). Sales figures reflect online channel sell-through and do not include offline retail. YoY comparisons are calculated against the corresponding 2024 period. For full methodology and additional category insights, see the complete Health & Wellness 2025 whitepaper.
This content adheres to Moojing's editorial standards .
